FDA · Class I · August 26, 2026

Bard Access Systems recall: BD Needle Kit for Powered Driver 15mm x 15Ga

Bard Access Systems, Inc. is recalling BD Needle Kit for Powered Driver 15mm x 15Ga – 80,200. The U.S. Food and Drug Administration published the recall on August 26, 2026; it began on July 30, 2026. Distributed in 32 states (Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia).

Most serious Class I is the most serious level: a reasonable probability that using or eating the product will cause serious health problems or death.

An FDA laboratory that tests medical devices
Illustration: An FDA laboratory that tests medical devices – not the recalled product. Photo: U.S. Food and Drug Administration, public domain.
ProductBD Needle Kit for Powered Driver 15mm x 15Ga
BrandBard Access Systems
CompanyBard Access Systems, Inc.
TypeMedical devices
ClassificationClass I
Recall dateJuly 30, 2026
Published by FDAAugust 26, 2026
Quantity80,200
Recall ID99484
As listed by FDA

Recalled products

  1. BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35mm x 15Ga, REF: D015351NK, BD Needle Kit for Powered Driver 45mm x 15Ga, REF: D015451NK, BD Needle Kit for Powered Driver 55mm x 15Ga, REF: D015551NK
    FDA recall number
    Z-2872-2026
    Codes, lots and dates
    REF/UDI-DI/Lot(Expiration): D015151NK/00801741163586/BSLC9275(2026-08-03), BSLC9563(2026-08-13), BSLC9567(2026-08-25), BSLC10103(2026-09-27), BSLC10516(2026-11-01), BSLC10526(2026-11-16), BSLC10872(2026-12-09), BSLC11216(2028-07-02), BSLC11456(2028-07-23); D015251NK/00801741163678/BSLC9467(2026-08-10), BSLC9575(2026-09-20), BSLC10105(2026-10-04), BSLC10522(2026-11-07), BSLC10868(2026-12-02), BSLC11212(2028-06-18), BSLC11454(2028-07-17), BSLC11463(2028-08-07), BSLC11884(2028-09-15), BSLC11890(2028-09-18), BSLC12082(2028-10-08), BSLC12115(2028-10-20), BSLC12123(2028-10-22); D015351NK/00801741163593/BSLC11458(2028-07-24); 00801741163678/BSLC9277(2026-08-04), BSLC9485(2026-08-12), BSLC9569(2026-08-26), BSLC10099(2026-09-07), BSLC10514(2026-10-16), BSLC10518(2026-10-21), BSLC10524(2026-11-08), BSLC10870(2026-12-03), BSLC10874(2028-06-12), BSLC11218(2028-07-07); D015451NK/00801741163609/BSLC9279(2026-08-06), BSLC9565(2026-08-17), BSLC9571(2026-09-07), BSLC10101(2026-09-17), BSLC10456(2026-10-14), BSLC10520(2026-10-22), BSLC10866(2026-11-21), BSLC11214(2028-06-23), BSLC11450(2028-07-09), BSLC11460(2028-07-31), BSLC11873(2028-08-13), BSLC11888(2028-09-25), BSLC12007(2028-10-02), BSLC12105(2028-10-15); D015551NK/00801741163616/BSLC9465(2026-08-07), BSLC9573(2026-09-26), BSLC10107(2026-10-02), BSLC10528(2026-11-20), BSLC11452(2028-07-10)
    Quantity
    80,200
    Classification
    Class I
Exactly as the agency lists them

Identifiers and details

FDA event ID
99484
Initiated
Voluntary: Firm initiated
Status
Ongoing
Firm location
Salt Lake City, UT, United States

Why it was recalled

The reason the FDA lists: “After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove obturator, due to it locking to the needle hub, due to out-of-tolerance dimensions and IFU unclarity, which may result in new needle placement, which may result in delayed therapy”

Where it was sold

32 states: Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia. Distribution as the FDA records it: “US: MA, FL, IA, SC, IL, NY, UT, NJ, ID, IN, PA, CA, TX, OH, MO, VA, MD, NC, AL, MN, CO, KY, LA, NV, OK, MS, AZ, MI, GA, AR, KS, TN. OUS: CA, SG”

What to do

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Official notice: FDA Enforcement Report record (event 99484, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.

Same brand

Other Bard Access Systems recalls

DateRecallProblemAgency
Sep 23, 2026Bard Access Systems recall: Power-Trialysis Short-Term Straight Dialysis Catheter and 1 more productMedical devices · 149521; 22,980this is a downstream recall of class I recall RES 98777
Most serious
FDA
Class I
Latest

Other medical device recalls

DateRecallProblemAgency
Oct 7, 2026Draeger recall: VentStar Resus NeoMedical devices · 1,063,643 unitsPotential cracks in the hose, which could lead to leakage or the hose falling off.
Most serious
FDA
Class I
Oct 7, 2026Medline Industries recall: Medline Basic Homecare Beds and Medlite Homecare Beds and Accessories and 1 more productMedical devices · 771,127 totala fire hazard
Most serious
FDA
Class I
Oct 7, 2026Karl Storz Endoscopy recall: HOPKINS Telescope 30¿Medical devices · 6 eyepiecesDue to incorrect inside packaging label for eyepiece.
Serious
FDA
Class II
Oct 7, 2026Noxbox recall: NOxBOXi Nitric Oxide Delivery SystemMedical devices · 1,667 unitsPotential for irregular oxygen readings due to a manufacturing issue affecting certain oxy…
Serious
FDA
Class II
Oct 7, 2026Siemens Healthcare Diagnostics recall: Atellica CH Revised C-Reactive ProteinMedical devices · 42940 units (3938 US, 39002 OUS)The potential for falsely elevated results.
Serious
FDA
Class II
Oct 7, 2026Tandem Diabetes Care recall: T:slim Mobile ApplicationMedical devices · 177A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a sof…
Serious
FDA
Class II
FAQ

About this recall

Is Bard Access Systems BD Needle Kit for Powered Driver 15mm x 15Ga recalled?

Yes. Bard Access Systems, Inc. recalled it on July 30, 2026; FDA published it August 26, 2026 (Class I). Only the lots, dates or models listed on this page are included.

Why was it recalled?

After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove obturator, due to it locking to the needle hub, due to out-of-tolerance dimensions and IFU unclarity, which may result in new needle placement, which may result in delayed therapy

What should I do if I have it?

Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.

Where was it sold?

In 32 states (Alabama, Arizona, Arkansas, California, Colorado, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia).

Recalls

More recalls

Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.

Cookies

We measure traffic so we know which stories you care about. You can change your choice at any time.